uSINE-PAMS Artificial Intelligence Driven, Ultrasound-Guided Lumbar Puncture to Improve Procedural Accuracy

Sponsor
National Neuroscience Institute (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05824546
Collaborator
HiCura Medical Pte Ltd (Other)
100
1
2
11
9.1

Study Details

Study Description

Brief Summary

This study aims to test the effectiveness of uSINE-PAMS technology for lumbar puncture compared to traditional landmark-based technique. uSINE is a machine-learning software designed to aid the operators in ultrasound-guided lumbar puncture while PAMS is a two-part hardware to translate data from ultrasound to accurate needle insertion and angulation.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Intervention Arm (uSINE-PAMS technique):
  • Procedure: Control Arm (traditional landmark-based technique):
N/A

Detailed Description

Lumbar puncture (LP) is a routine invasive procedure performed for the diagnosis and treatment of central nervous system disorders. The traditional landmark-based method is associated with a high failure rate of up to 50%, leading to complications including back pain and epidural hematoma, diagnostic delay, and increased healthcare costs. The success rate has been improved with ultrasound guided LP but the use of ultrasound-guided LP has not been widespread due to inadequate training in ultrasound use and the inability to translate information derived from ultrasonography to the LP procedure. uSINE-PAMS was designed to address these challenges: uSINE is a machine-learning software to aid the operators in ultrasound-guided LP; PAMS is a two-part hardware to translate data from ultrasound to accurate needle insertion and angulation.

This study consists of a pilot phase to test the usability of uSINE-PAMs and allow for improvement in technology and clinical workflow for uSINE-PAMS. In the pilot phase, experienced NNI clinicians who have participated in a previous healthy volunteer study and have been trained to use uSINE will be the operators performing the uSINE-PAMS-guided lumbar puncture. During and upon completion of the study, challenges in the use of uSINE and PAMS to conduct LP as well as in the implementation of uSINE-PAMS in the clinical workflow will be determined and addressed prior to the main study, a randomized controlled trial. Ten patients will be recruited in this pilot phase.

Following the pilot phase, the main study (randomized controlled trial) will be conducted to evaluate the effectiveness of uSINE-PAMS-guided lumbar puncture. 100 patients will be randomized to undergo LP using uSINE-PAMS guided technique or traditional landmark-based method. The investigators hypothesize that uSINE-PAMS guided lumbar puncture will achieve at least 20% improvement in first pass success rate of obtaining cerebrospinal fluid compared to traditional landmark-based technique, therefore leading to reduction in complication rates.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
uSINE-PAMS Artificial Intelligence Driven, Ultrasound-Guided Lumbar Puncture to Improve Procedural Accuracy
Anticipated Study Start Date :
May 1, 2023
Anticipated Primary Completion Date :
Mar 31, 2024
Anticipated Study Completion Date :
Mar 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Intervention Arm

Patients will undergo LP using uSINE-PAMS-guided technique

Procedure: Intervention Arm (uSINE-PAMS technique):
Patients will be lying in a lateral recumbent position and in a fetal position with the neck, back and limbs held in flexion. L3-L4 inter-vertebral space will be identified by palpation of external landmarks of the patients' iliac crests and spinous process of lumbar vertebrae L3, L4 and L5 and confirmed using uSINE-integrated ultrasound. The angle of needle during needle advancement will also be determined using the uSINE-integrated ultrasound. Markings on the patients' skin surface will be made using PAMS (non-sterile component) to enable relocation of the site and angle of the needle entry. Patients' back will be cleaned and draped using aseptic technique. Next, local anaesthesia is infiltrated into the previously identified needle entry site before the LP needle is inserted with location and angulation according to PAMS (sterile component) guidance.

Active Comparator: Control Arm

Patients will undergo LP using traditional landmark-based method

Procedure: Control Arm (traditional landmark-based technique):
Patients will be lying in a lateral recumbent position and in a fetal position with the neck, back and limbs held in flexion. L3-L4 inter-vertebral space will be similarly identified by palpation of external landmarks of iliac crests and spinous process of lumbar vertebrae L3, L4 and L5. Markings on the patients' skin surface will be made with a washable marker or any other methods according to the operator's preference to enable relocation of the site of the needle entry. Patients' back will be cleaned and draped using aseptic technique. Next, local anaesthesia is infiltrated into the previously identified needle entry site before the LP needle is inserted into marked entry site.

Outcome Measures

Primary Outcome Measures

  1. To compare the first pass success rate of obtaining cerebrospinal fluid using uSINE-PAMS-guided technique against the traditional landmark-based method [During procedure]

    First pass is defined as the first LP attempt without withdrawing the LP needle out of the skin.

Secondary Outcome Measures

  1. To compare the number of needle redirections using uSINE-PAMS-guided technique with that using the traditional landmark-based method [During procedure]

    Needle redirection is defined as the number of times the LP needle was repositioned to obtain the CSF without withdrawing out of the skin.

  2. To compare the rate of traumatic LP using uSINE-PAMS-guided technique against the traditional landmark-based method [1 hour after procedure]

    Traumatic LP is defined as needle-induced blood (>5 red blood cells/ul) in the cerebrospinal fluid; Cases where red blood cells are expected in the cerebrospinal fluid will be excluded from this analysis.

  3. To compare the pain score from LP using uSINE-PAMS-guided technique with that from LP using the traditional landmark-based method [Immediately after procedure]

    Pain score will be assessed using the Universal Pain Assessment Tool which has a scale of 0-10.

  4. To compare the rate of back pain that develops within 24 hours of the LP using uSINE-PAMS-guided technique with the traditional landmark-based method [Approximately 24 hours after procedure]

    Pain score will be assessed using the Universal Pain Assessment Tool which has a scale of 0-10.

Other Outcome Measures

  1. To compare the rate of serious complications from LP using uSINE-PAMS-guided technique with that from LP using the traditional landmark-based method [Within 1 week of procedure]

    Serious complications include spinal hematoma, subdural hematoma, central nervous system infection and headaches requiring hospitalizations

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 105 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
INCLUSION CRITERIA:
  • Patients planned for lumbar puncture as part of their clinical care

  • 21 years of age or older

  • Able to provide informed consent

EXCLUSION CRITERIA:
  • Allergy to ultrasound gel

  • Previous lumbar spinal instrumentation

  • Patients with suspected spinal epidural abscess or any other infection at the potential site of needle entry on the back

  • Possible raised intracranial pressure with risk of cerebral herniation, including presence of obstructive hydrocephalus, intracranial space-occupying lesion and cerebral edema

  • Presence of significant thrombocytopenia (platelet <100k) or other bleeding diathesis; patients on antiplatelet and/or anticoagulation may be included if their antiplatelet and/or anticoagulation can be and are stopped for an adequate duration prior to lumbar puncture according to the institution guidelines.

Contacts and Locations

Locations

Site City State Country Postal Code
1 National Neuroscience Institute (NNI) Singapore Singapore

Sponsors and Collaborators

  • National Neuroscience Institute
  • HiCura Medical Pte Ltd

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
National Neuroscience Institute
ClinicalTrials.gov Identifier:
NCT05824546
Other Study ID Numbers:
  • uSINE
First Posted:
Apr 21, 2023
Last Update Posted:
Apr 21, 2023
Last Verified:
Apr 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 21, 2023